Author： Winckler Thomas
Publisher： Govi-Verlag
ISSN： 2195-2175
Source： PHARMAKON, Vol.1, Iss.3, 2013-05, pp. : 201-202
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
11 Years of Cyanopyrrolidines as DPP-IV Inhibitors
Current Topics in Medicinal Chemistry, Vol. 7, Iss. 6, 2007-03 ,pp. :
Access to resources
Recommend
DPP-IV inhibitors could be cost-effective for T2DM
Inpharma, Vol. 1, Iss. 1642, 2008-01 ,pp. :
DPP-IV inhibitors could be cost-effective for T2DM
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 556, 2008-01 ,pp. :
DPP-IV inhibitors/sitagliptin: First report of spermatogenesis abnormalities: case report
Reactions Weekly, Vol. 1, Iss. 1371, 2011-01 ,pp. :